CaIPLA2 Polyclonal Antibody, APC Conjugated, Rabbit

Artikelnummer: BSS-BS-6709R-APC
Artikelname: CaIPLA2 Polyclonal Antibody, APC Conjugated, Rabbit
Artikelnummer: BSS-BS-6709R-APC
Hersteller Artikelnummer: bs-6709R-APC
Alternativnummer: BSS-BS-6709R-APC-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF, WB
Konjugation: APC
Alternative Synonym: GVI, PLA2, INAD1, NBIA2, iPLA2, NBIA2A, NBIA2B, PARK14, PNPLA9, CaI-PLA2, IPLA2-VIA, iPLA2beta, 85/88 kDa calcium-independent phospholipase A2, Group VI phospholipase A2, GVI PLA2, Intracellular membrane-associated calcium-independent phospholipase A2 beta, iPLA2-beta, Patatin-like phospholipase domain-containing protein 9, PLA2G6, PLPLA9
Catalyzes the release of fatty acids from phospholipids. It has been implicated in normal phospholipid remodeling, nitric oxide-induced or vasopressin-induced arachidonic acid release and in leukotriene and prostaglandin production. May participate in fas mediated apoptosis and in regulating transmembrane ion flux in glucose-stimulated B-cells. Has a role in cardiolipin (CL) deacylation. Required for both speed and directionality of monocyte MCP1/CCL2-induced chemotaxis through regulation of F-actin polymerization at the pseudopods. Isoform ankyrin-iPLA2-1 and isoform ankyrin-iPLA2-2, which lack the catalytic domain, are probably involved in the negative regulation of iPLA2 activity.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 8398
UniProt: O60733
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human CaI-PLA2/PLA2G6
Target-Kategorie: CaI-PLA2
Application Verdünnung: WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)